The use of homologous recombination to modify genes in embryonic stem (ES) cells provides a powerful means to elucidate gene function and create disease models 1 . Application of this technology to engineer genes in rats has not previously been possible because of the absence of germline-competent ES cells in this species. We have recently established authentic rat ES cells 2,3 . Here we report the generation of gene knockout rats using the ES-cell-based gene targeting technology. We designed a targeting vector to disrupt the tumour suppressor gene p53 (also known as Tp53) in rat ES cells by means of homologous recombination. p53 gene-targeted rat ES cells can be routinely generated. Furthermore, the p53 gene-targeted mutation in the rat ES-cell genome can transmit through the germ line via EScell rat chimaeras to create p53 gene knockout rats. The rat is the most widely used animal model in biological research 4-7 . The establishment of gene targeting technology in rat ES cells, in combination with advances in genomics and the vast amount of research data on physiology and pharmacology in this species, now provide a powerful new platform for the study of human disease.
The use of homologous recombination to modify genes in embryonic stem (ES) cells provides a powerful means to elucidate gene function and create disease models 1 . Application of this technology to engineer genes in rats has not previously been possible because of the absence of germline-competent ES cells in this species. We have recently established authentic rat ES cells 2, 3 . Here we report the generation of gene knockout rats using the ES-cell-based gene targeting technology. We designed a targeting vector to disrupt the tumour suppressor gene p53 (also known as Tp53) in rat ES cells by means of homologous recombination. p53 gene-targeted rat ES cells can be routinely generated. Furthermore, the p53 gene-targeted mutation in the rat ES-cell genome can transmit through the germ line via EScell rat chimaeras to create p53 gene knockout rats. The rat is the most widely used animal model in biological research [4] [5] [6] [7] . The establishment of gene targeting technology in rat ES cells, in combination with advances in genomics and the vast amount of research data on physiology and pharmacology in this species, now provide a powerful new platform for the study of human disease.
In the past two decades, gene targeting in mouse ES cells has been used as a unique and powerful tool for elucidating gene function and addressing fundamental biological questions in mammals 1 . This ES-cell-based gene targeting technology allows us to create precise and conditional gene replacements (knock-in) or loss-of-function mutations (knockout) of the chosen locus. So far, this technology is only available for the mouse because of the inability to establish germline-competent ES-cell lines from other species. The rat is a more widely used model for studying human normal and disease processes and for testing drug efficacy and toxicity before human clinical trials [4] [5] [6] [7] . Although several technologies have been used to alter rats genetically [8] [9] [10] [11] [12] [13] [14] , our ability to manipulate the rat genome and create rat disease models is greatly limited without the ES-cell-based gene targeting technology. Recently, we developed the 3i/2i culture system that enabled the derivation of germline-competent rat ES cells for the first time 2, 3, 15 . To investigate whether the ES-cell-based gene targeting technology developed for the mouse can be generally applied to the rat, we targeted the p53 gene in rat ES cells.
p53 is a tumour suppressor, and mutations in the p53 gene are the most frequently observed genetic lesions in human cancers 16 . The rat p53 gene locus on chromosome 10 consists of ten exons with the translation start codon located within exon 2 ( Fig. 1a ). We designed a targeting vector to disrupt the p53 gene via homologous recombination in rat ES cells (Fig. 1a ). The vector contained 6.7-kilobase (kb) 59 and 1.6kb 39 homology arms which were amplified from dark agouti (DA) rat ES-cell genomic DNA. Positive selection was provided by a CAG-EGFP-IRES-Pac cassette and negative selection by a phosphoglycerate kinase 1-diphtheria toxin-A chain (PGK-DTA) selection cassette. Correctly targeted rat ES cells expressed puromycin N-acetyl transferase (Pac) and green fluorescent protein (GFP). The PGK-DTA cassette was placed at the end of the 39 homology arm and was not incorporated into the chromosomes when homologous recombination occurred. Random integration of PGK-DTA was expected to reduce the number of puromycin-resistant ES cell clones with random targeting vector integrations, enabling the enrichment of correctly targeted cells 17 .
In the targeted cells, CAG-EGFP-IRES-Pac replaced exons 2-5 of p53 ( Fig. 1b ), resulting in a loss-of-function mutation (p53 tm1(EGFP-pac) ). Polymerase chain reaction (PCR) primers were used to screen puromycin-resistant rat ES cells for homologous recombination with the 39 arm of homology. The 59 PCR primer (TGCGGTGGGCTCTATGGCTTCT) was located in the Pac gene. The 39 PCR primer (CGGACGATGGACATCTGGTGGA) was located between exon 8 and exon 9. The size of the expected PCR product in correctly targeted cells was 2,140 base pairs (bp). We also designed 59, 39 and internal hybridization probes for further confirmation of rat p53 gene targeting by Southern blot analysis ( Fig. 1a, b) .
To test whether the rat p53 gene could be disrupted via homologous recombination, we introduced the p53 gene targeting vector into DA rat ES cells by electroporation. Puromycin was added to the culture medium to select for transfected cells. We picked and expanded puromycin-resistant colonies and identified correctly targeted cells by PCR and Southern blot analysis. We transfected two male DA rat ES cell lines, DAc8 and DAc4, with the p53 vector. As summarized in Supplementary Table 1 , we obtained 14 p53 gene-targeted DA rat ES-cell clones. Targeting efficiencies in DAc8 and DAc4 ES cells were 1.12% and 3.70%, respectively. Detailed PCR and Southern blot screening results are provided in Supplementary Figs 1 and 2.
One p53 gene-targeted rat ES-cell clone, DAc8-p53-1, was used to examine transmission of p53 tm1(EGFP-pac) through the rat germ line. DAc8-p53-1 rat ES cells were GFP positive as expected ( Fig. 2a ). The correct targeting event in the DAc8-p53-1 cells was also verified by Southern blot analysis using 59, 39 and internal probes ( Fig. 2b) confirm further that one of the p53 alleles was disrupted in DAc8-p53-1 rat ES cells, we designed PCR primers to amplify and sequence the genomic DNA flanking the p53 gene-targeted region (Fig. 2c ). The results showed that the p53 targeting vector replaced the endogenous p53 locus via homologous recombination ( Fig. 2d-g ). DAc8-p53-1 EScell rat chimaeras were prepared by microinjecting the cells into 79 blastocysts collected from E4.5 Fischer 344 (F344) rats. Microinjected blastocysts were transferred to pseudo-pregnant female Sprague-Dawley rats. Twenty-four live-born pups were produced, among which ten male and six female pups were pigmented, indicating contributions from the DAc8-p53-1 ES cells ( Supplementary Fig. 3 ). The ten male chimaeras were mated with Sprague-Dawley female rats to test for germline transmission of the targeted p53 allele. All ten male chimaeras were fertile and produced over 600 offspring, among which one carried the DA rat ES-cell genome as identified by the appearance of agouti coat colour ( Supplementary Fig. 4a ). However, PCR genotyping results showed that this germline animal did not inherit the gene-targeted p53 allele ( Supplementary Fig. 4b, c ). Failure of mouse ES cells to contribute to the germ line is often caused by chromosomal abnormalities in ES cells 18 . This is also likely to be true for rat ES cells. We examined the karyotype of DAc8-p53-1 rat ES cells and found that over 65% of the cells were polyploid ( Supplementary Fig. 5a ). This is probably the reason for their low germline transmission efficiency. From mouse ES cell studies, it has been suggested that chromosomal abnormalities are associated with a selective growth advantage, and that the use of small, slower growing clones rather than large, rapidly growing clones for blastocyst injection will significantly improve the germline transmission rate 18 . We investigated whether germline competency of DAc8-p53-1 rat ES cells could be improved through subcloning. DAc8-p53-1 rat ES cells were plated at a clonal density as has been reported for mouse ES cells 19, 20 . Around 10% of the cells formed round and compact colonies ( Supplementary Fig. 5b ). These colonies were picked and expanded to establish subclones. We karyotyped 20 DAc8-p53-1 rat ES-cell subclones and identified 2 subclones with euploid chromosome numbers ( Supplementary Fig. 5c ). The subclones grew as round and compact colonies ( Supplementary Fig. 5d ). The subclones were microinjected into a total of 39 F344 rat blastocysts. Two male chimaeras were produced and one was a germline chimaera ( Fig. 3a ). This germline chimaera generated 76 offspring among which were 6 germline pups. Three of the germline pups, one male and two female, were GFP positive, indicating the inheritance of the p53 tm1(EGFP-pac) allele (Fig. 3b ). Genotyping and Southern blot analysis further confirmed that these three pups were p53 heterozygote animals carrying one wild-type allele and one targeted p53 allele ( Fig. 3c, d ).
To generate p53 homozygous (knockout) rats, we intercrossed the three p53 heterozygote rats. Twelve pups were produced and nine were GFP-positive ( Fig. 4a ). Genotyping analysis revealed that among the nine GFP-positive pups, seven were heterozygous and two were homozygous for the p53 tm1(EGFP-pac) allele (Fig. 4b ). Northern and western blot analyses further confirmed the absence of p53 messenger RNA and protein in the p53 homozygote pup (Fig. 4c, d) .
We have demonstrated that gene targeting via homologous recombination can be achieved in authentic pluripotent rat ES cells. Notably, the gene-targeted mutation in rat ES cells can transmit through the germ line to produce gene knockout rats. The availability of ES-cell-based genetargeting technology in the rat enables us to produce sophisticated and precise genetic modifications, such as subtle mutations, gene replacements and chromosome rearrangements 21 . Importantly, by combining the Cre/loxP and inducible gene expression systems [22] [23] [24] , we can introduce temporal control and tissue-specific changes in genes in rat models via ES-cell-mediated genetic modifications. Owing to the wide use of rats in physiological and pharmacological studies, we anticipate that many of the rat models generated using ES-cell-mediated gene targeting will provide a powerful platform for the study of human health and disease.
METHODS SUMMARY
p53 gene targeting in rat ES cells. Rat ES cells were routinely maintained in 2i conditions as described 2,3 . The rat p53 gene targeting vector was constructed by the insertion of 6.7-kb 59 and 1.6-kb 39 homology arms into the pCAG-EGFP-IRES-Pac plasmid. The rat p53 gene-targeting vector was introduced into DA rat ES cells by electroporation. After electroporation, 0.5 mg ml 21 puromycin was added to select for transfected cells. The emerging puromycin-resistant colonies were picked and expanded. p53 gene-targeted rat ES-cell clones were identified by PCR screening and Southern blot analysis. Generation of p53 gene knockout rats. p53 gene-targeted DA rat ES cells were injected into blastocysts collected from E4.5 timed-pregnant F344 rats as described for mouse ES cell injections 25 . ES-cell-injected blastocysts were transferred to E3.5 pseudo-pregnant Sprague-Dawley rats. Contribution of the injected p53 gene-targeted DA rat ES cells in the resulting chimaeras was identified by the appearance of agouti coat colour. Male chimaeras were bred with Sprague-Dawley female rats to produce offspring carrying the p53 gene-targeted mutation. p53 heterozygote rats were intercrossed to produce p53 knockout rats. Animal experiments were performed according to the investigator's protocols approved by the USC Institutional Animal Care and Use Committee (IACUC). a, Offspring generated by intercrossing p53 tm1(EGFP-pac) heterozygote rats. b, Genotyping analysis on tail biopsies using PCR primers shown in Fig. 3c . M, 100 bp DNA marker; 1-9, the nine GFP-positive offspring; 3 and 7, the two p53 tm1(EGFP-pac) homozygote pups; 10-12, the three GFP-negative offspring. Rat ES cell culture. Rat ES cells were cultured at 37 uC in a humidified 5% CO 2 incubator. They were routinely maintained on mitotically inactivated CF-1 MEFs with N2B27 medium supplemented with 3 mM CHIR99021 and 1 mM PD0325901 (2i medium) 2, 3, 15 . Rat ES cells attach loosely to the feeders, so it is very easy to detach rat ES cells from the feeders by mechanical pipetting. Rat ES cells were passaged every 2-3 days. For passaging, rat ES cells were detached from feeders by pipetting and harvested by centrifugation. 0.025% trypsin/EDTA was added to the cell pellet to prepare a single cell suspension. 0.025% trypsin/EDTA solution was prepared by adding 5 ml of 2.5% trypsin (Invitrogen), 5 ml of chicken serum (Sigma) and 0.5 ml of 0.5 M EDTA (Invitrogen) to 500 ml sterile PBS. After trypsinization, GMEM/10% FCS medium was added to neutralize the trypsin. The cells were collected by centrifugation and re-suspended in 2i medium. Rat ES cells were plated at a density of 8 3 10 4 cells cm 22 so that they reached 60-80% confluency after 2-3 days in culture.
Construction of the rat p53 gene-targeting vector. Gene-targeting vectors must contain a drug-selectable marker to select recombinants. The selection marker gene is most commonly controlled by the PGK promoter in most mouse genetargeting vectors 26 . Initially, we constructed the rat p53 gene-targeting vector using the PGK promoter to drive the expression of the EGFP-IRES-Pac selection cassette. Less than 20 puromycin-resistant colonies grew up after the electroporation of 100 mg of the p53 gene-targeting vector into 7 3 10 6 rat ES cells. Rat ES cells are very sensitive to drug selection and we reasoned that low PGK promoter activity in rat ES cells might prevent the isolation of drug-resistant colonies. The CMV early enhancer/chicken b-actin (CAG) promoter has been shown to drive high-level gene expression in both mouse and rat ES cells 3, 27, 28 .
We compared the activity of PGK and CAG promoters in rat ES cells using the Dual-Luciferase Reporter Assay (Promega). The activity of the CAG promoter was 36 times higher than that of the PGK promoter. We then constructed a p53 gene-targeting vector using the CAG promoter to drive the expression of the EGFP-IRES-Pac selection cassette. The pCAG-EGFP-IRES-Pac plasmid was used as the backbone for the construction of rat p53 gene-targeting vector. The 59 and 39 homology arms were amplified from DA rat genomic DNA using the Expand High Fidelity PCR System (Roche). The following primer pairs were used to amplify the homology arms: 59-GTCGACAGAAGTTCTCGGAGCG GGTGCTGAACT-39, 59-ATCCTCCATGACAGTTATCTGCA-39 (for 59 homology arm); 59-TAGGATCCACAAAGTCACAGAGCCACTTTCA-39, 59-TAGGA TCCCCTCTGACTTATTCTTGCTCTTAG-39 (for 39 homology arm). PCR products were subcloned into the TOPO vector (Invitrogen) and confirmed by DNA nucleotide sequencing. To construct the rat p53 gene-targeting vector, the 6.7-kb 59 homology arm was first inserted into the SalI site of the pCAG-EGFP-IRES-Pac plasmid, followed by the insertion of the 1.6-kb 39 homology arm into the BamHI site. Finally, the PGK-DTA-polyA negative selection cassette was inserted at the end of the 39 homology arm.
Introducing the p53 gene-targeting vector into rat ES cells by electroporation.
The passage numbers of DAc8 and DAc4 rat ES cell lines used for performing p53 gene targeting were 32 and 14, respectively. The majority of rat ES cells attach loosely to feeders and grow as round and compact colonies, whereas a minority of rat ES cells form flat and adherent colonies. We pre-selected adherent DAc8 rat ES cells and kept expanding them as adherent culture. It took over 15 passages to generate a high proportion of adherent DAc8 rat ES cells in culture and this was the reason why we used the high passage number of DAc8 rat ES cells for the first p53 gene-targeting experiment. We found that rat ES cells grown as adherent cells in culture are mostly karyotypically abnormal. DAc8 and DAc4 rat ES cells remain euploid after 35-40 passages if they are passaged using the method described in the 'Rat ES cell culture' section. Rat ES cells were dissociated into single cells using 0.025% trypsin/EDTA and trypsin was neutralized with GMEM/10% FCS medium. After washing twice with PBS, 7 3 10 6 rat ES cells were mixed with 100 mg of linearized p53 genetargeting vector in 0.8 ml PBS and transferred to a 4-mm-gap Gene Pulser Cuvette (Bio-Rad). The cuvette was placed in the electroporation holder of the Bio-Rad Gene Pulser XCellTM (Bio-Rad) and electroporated at 200 V, 500 mF.
After electroporation, the cells were plated into three 100-mm tissue culture dishes pre-seeded with mitotically inactivated DR-4 MEFs and cultured in 2i medium. Rat ES cells are very sensitive to drug selection compared to mouse ES cells. The following drug selection scheme was applied. First, 1 day after electroporation, puromycin was added to the medium at 0.5 mg ml 21 . The cells were incubated in the presence of puromycin for 2 days. After this incubation, the puromycin was removed and fresh rat ES cell culture medium was added. The cells were then incubated in the absence of puromycin for 1 day. This process represents one 'cycle' in the selection strategy. Selection was completed after three consecutive cycles. The emerging puromycin-resistant colonies were picked and expanded. PCR screening for rat p53 homologous recombination. Puromycin-resistant colonies were expanded and split into two duplicate 96-well plates, one of which was used for PCR screening while the other remained in culture. Genomic DNA was extracted from each clone using ZR-96 Quick-gDNA kit (Zymo research) and eluted in 30 ml of distilled water. The PCR primer pair for screening correctly targeted cells was described in the main text. PCR reactions were performed using the following cycle conditions: 95 uC for 2 min to denature the DNA, then 95 uC for 20 s, 60 uC for 20 s and 72 uC for 1 min, for 40 cycles. PCR amplification products were separated on 1% agarose gels. The expected size fragment from correctly targeted p53 cells was 2,140 bp. Subcloning and karyotyping. For subcloning, 1 3 10 4 DAc8-p53-1 rat ES cells were plated onto a 100-mm dish pre-seeded with CF-1 MEFs and cultured in 2i medium. The culture medium was changed every other day. Eight days after plating, colonies with a round and compact morphology were picked and each colony was placed into a drop of 10 ml 0.025% trypsin/EDTA. After incubation at room temperature for 3-5 min, the colonies were dissociated into single cells by pipetting and directly transferred to a 96-well plate pre-seeded with CF-1 MEFs and cultured in 2i medium supplemented with 1% FCS (addition of 1% FCS is necessary to neutralize trypsin). The next day, FCS/trypsin containing 2i medium was carefully removed and fresh 2i medium was added. The cells were then passaged and expanded as described above. For karyotyping, rat ES cells were plated onto 6-well plates at a density of 1 3 10 6 cells per well. One day after plating, 100 ng ml 21 colcemid (Sigma) was added to the culture which was incubated for 2 h. The rat ES cells were then harvested for metaphase preparation by standard methods 25 . Blastocyst injection. Blastocysts were collected from E4.5 timed-pregnant F344 rats. After washing through several drops of M2 medium (Sigma), blastocysts were transferred to an oil overlaid microdrop of M16 medium (Sigma) in a 35-mm plastic tissue culture dish and incubated for 2-4 h at 37 uC in a humidified 5% CO 2 incubator to allow the expansion of the blastocoel cavity. 12-15 p53 gene-targeted rat ES cells were injected into each well-expanded blastocyst using the same technique as described for mouse ES-cell injections 25 . ES-cell-injected blastocysts were transferred to E3.5 pseudo-pregnant Sprague-Dawley rats as follows. First, pseudo-pregnant rats were anaesthetized by intraperitoneal injection of 50 mg kg 21 ketamine (Bioniche Pharma USA) and 10 mg kg 21 xylazine (Akorn). The uterus was exteriorized and a hole was made in the uterus with a 27 gauge needle a few millimetres down from the utero-tubal junction. 8-10 ES-cell-injected blastocysts were transferred into the uterus with a mouth-controlled embryo transfer pipette. At the end of the procedure, the rat was placed in a clean cage and kept warm until it recovered from anaesthesia. Pups were normally born 18-19 days after the transfer of blastocysts. Contribution of the p53 gene-targeted rat ES cells to the resulting chimaeras was identified by the appearance of agouti coat colour. Male chimaeras were bred with Sprague-Dawley female rats to produce offspring carrying the p53 tm1(EGFP-pac) mutation. Southern blot analysis. Genomic DNA was extracted from rat ES cells or rat tail biopsies using Puregene Tissue Core Kit A (Qiagen). 10 mg genomic DNA from each sample was used for Southern blot analysis. After digestion with SpeI (for 59 and internal probes) or HindIII (for 39 probe), the genomic DNA samples were analysed by gel electrophoresis with a 1% agarose gel. After electrophoresis, the gel was denatured, neutralized and blotted by capillary transfer with 203 SSC on a nylon membrane as described 29 . The DNA membrane was fixed and hybridized with digoxigenin-labelled Southern blot hybridization probes according to the manufacture's instructions (Roche).
Genotyping. Rat tail genomic DNA was extracted using Puregene Tissue Core Kit A (Qiagen). 100 ng of genomic DNA from each sample was mixed with PCR primers and used to amplify genomic DNA with Paq5000 DNA polymerase (Stratagene). Thermal cycling conditions were: 95 uC for 2 min to denature the DNA, followed by 95 uC for 20 s, 62 uC for 20 s and 72 uC for 20 s for 40 cycles. Northern blot analysis. Total RNA was extracted from different organs of 2-week-old wild-type, p53 heterozygote and p53 homozygote rats using the RNAeasy kit (Qiagen). 3 mg total RNA from each sample was separated by gel electrophoresis with a 1% denaturing formaldehyde gel in 13 MOPS buffer and blotted onto positively charged nylon membrane in 203 SSC. The RNA membrane was fixed by ultraviolet-crosslinking and hybridized with the
